MERCK SHARP & DOHME CORP. v. ALBRECHT, 587 U.S. ___ (2019)

Issues: Federal Drug Administration (FDA), Federal Preemption, Products Liability, Torts

587 U.S. ___ 139 S.Ct. 1668 (2019) MERCK SHARP & DOHME CORP., Petitioner v. Doris ALBRECHT, et al. No. 17-290.Supreme Court of United States. Argued January 7, 2019.Decided May 20, 2019. ON WRIT OF CERTIORARI TO THE UNITED STATES COURT OF APPEALS FOR THE THIRD CIRCUIT. Shay Dvoretzky, Washington, DC, for petitioner. Malcolm L. Stewart, […]

Read More

SANDOZ INC. v. AMGEN INC., 582 U.S. ___ (2017)

Issues: Biologics Price Competition and Innovation Act of 2009, Federal Drug Administration (FDA)

NOTE: Where it is feasible, a syllabus (headnote) will be released, as is being done in connection with this case, at the time the opinion is issued. The syllabus constitutes no part of the opinion of the Court but has been prepared by the Reporter of Decisions for the convenience of the reader. See United […]

Read More